Materials
AGC eyes Japanese output of mRNA to spur domestic COVID vaccines
Materials maker to invest in Yokohama plant, preparing for pandemics
Pharmaceuticals
Coronavirus
Japan's Shionogi says COVID pill reaches Phase 3 milestone
Success in trial of COVID treatment lifts shares 2.5% in Wednesday trade
Pharmaceuticals
Eisai-Biogen Alzheimer's drug slows cognitive decline
Japan drugmaker expects decision on FDA accelerated approval in early January
Pharmaceuticals
Japan's Shionogi seeks OK for COVID-19 pill in South Korea via tie-up
Emergency use authorization has been delayed in home market
Coronavirus
End of COVID pandemic is 'in sight,' WHO chief says
U.N. health agency gives its most upbeat assessment so far
COVID vaccines
CanSino's inhaled COVID vaccine gets emergency use approval in China
Company sees product's role as booster dependent on government purchases
Pharmaceuticals
Ricoh to launch $7m seed fund to back Japan's mRNA startups
Company targets fledgling businesses with eye toward boosting contract drugmaking
COVID vaccines
Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine
U.S. company accuses rival of copying mRNA technology from before pandemic
Business trends
Vietnam sees chain drugstores boom during COVID pandemic
New health-conscious consumers look for quality, deals outside mom-and-pop shops
Pharmaceuticals
Takeda gets approval for use of dengue inoculation in Indonesia
Japanese pharma to be first to sell vaccine abroad, with other markets planned
Pharmaceuticals
Takeda to sell dengue vaccine abroad, starting with Indonesia
Japan's first global vaccine can be used for children younger than existing shots
Coronavirus
U.K. first to approve omicron COVID shot with Moderna nod
Booster program set to begin in early autumn for those over 50, high-risk groups
Health Care
SwipeRx aims to double Indonesian pharmacy sign-ups
Singapore-based startup's CEO expects first profit in 2023
Pharmaceuticals
Chinese biopharma Taibang raises $300m, stirs relisting murmurs
Investment in former China Biologic led by Singapore, Abu Dhabi funds
Politics
Japan projects shortage of nearly 1m medical workers by 2040
Tokyo prepares by sharing tasks among doctors, nurses and pharmacists
Coronavirus
Japan delays approval of first domestic oral COVID-19 drug
Expert panel wants more data; Shionogi stock sinks 8.5% in Tokyo trade
Pharmaceuticals
Fujifilm to pump $1.6bn into biopharma in U.S. and Europe
Japan group to nearly quadruple capacity to meet rising demand for cancer drugs
DealStreetAsia
India's Biocon Biologics in funding talks with Baring PE Asia
Country's largest biopharmaceutical eyes valuation of over $100m
COVID vaccines
U.S. FDA advisers back COVID shots for children under 5
Officials in U.S. report 442 coronavirus deaths in young children so far
Climate Change
Takeda teams with GSK, other drugmakers to help cut supplier emissions
Over 1,000 vendors show interest in common system to estimate greenhouse gases
